Share of E. coli infections resistant to cephalosporins in United Arab Emirates

United Arab Emirates: Share of E. coli infections resistant to cephalosporins was 52.4% in 2022. ▲ Rising

Latest (2022)
52.4%
Change on year
up 1.4%
World rank
17th
of 46 countries
All-time high
54.1%
in 2020
All-time low
46.1%
in 2019
Years of data
6
2017–2022

Share of E. coli infections resistant to cephalosporins in United Arab Emirates, 2017–2022

02040602017201920222017: 48.1 %2018: 48.4 %2019: 46.1 %2020: 54.1 %2021: 51.7 %2022: 52.4 %

Source: World Health Organization – processed by Our World in Data. Measured in %.

Analysis

In 2022, share of e. coli infections resistant to cephalosporins in United Arab Emirates stood at 52.4%.

Compared with earlier readings it is up 1.4% on the previous year and up 9.0% over ten years.

United Arab Emirates ranks 17th of 46 countries on this measure, in the middle of the range.

Share of E. coli infections resistant to cephalosporins in United Arab Emirates, year by year

Annual values for Share of E. coli infections resistant to cephalosporins in United Arab Emirates, 2017 to 2022.
Year % Change
2017 48.1%
2018 48.4% +0.7%
2019 46.1% -4.9%
2020 54.1% +17.4%
2021 51.7% -4.5%
2022 52.4% +1.4%

Averages by decade

DecadeAverage LowestHighest Years
2010s 47.5% 46.1% 48.4% 3
2020s 52.7% 51.7% 54.1% 3

Countries ranked near United Arab Emirates

  1. 14 Jordan 57.2% compare
  2. 15 Saudi Arabia 52.8% compare
  3. 16 Lao People's Democratic Republic 52.6% compare
  4. 18 Georgia 46.5% compare
  5. 19 Philippines 43.9% compare
  6. 20 Cyprus 40.5% compare

See the full ranking of 46 places →

More reference data data for United Arab Emirates

All data for United Arab Emirates →

Frequently asked questions

What is share of e. coli infections resistant to cephalosporins in United Arab Emirates?
Share of e. coli infections resistant to cephalosporins in United Arab Emirates was 52.4% in 2022, according to World Health Organization – processed by Our World in Data.
What is the highest share of e. coli infections resistant to cephalosporins recorded in United Arab Emirates?
The highest recorded value was 54.1% in 2020.
What is the lowest share of e. coli infections resistant to cephalosporins recorded in United Arab Emirates?
The lowest recorded value was 46.1% in 2019.
How does United Arab Emirates rank for share of e. coli infections resistant to cephalosporins?
United Arab Emirates ranks 17th out of 46 countries with data for 2022.
Is share of e. coli infections resistant to cephalosporins rising or falling in United Arab Emirates?
Over the last ten years it is up 9.0%. The long-run trend across the full record is rising.
Where does this United Arab Emirates data come from?
The figures come from World Health Organization – processed by Our World in Data, published as part of Share of E. coli infections resistant to cephalosporins. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (Our World in Data).

Share, cite or embed this page

Cite this page

Share of E. coli infections resistant to cephalosporins in United Arab Emirates. Statizoid, drawing on World Health Organization – processed by Our World in Data. Retrieved 29 August 2026, from https://reference.statizoid.com/stat/share-of-e-coli-bloodstream-infections-due-to-antimicrobial-resistant-bacteria/united-arab-emirates/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://reference.statizoid.com/stat/share-of-e-coli-bloodstream-infections-due-to-antimicrobial-resistant-bacteria/united-arab-emirates/">Share of E. coli infections resistant to cephalosporins in United Arab Emirates</a> — Statizoid

About this data

Indicator
Share of E. coli infections resistant to cephalosporins
Unit
%
Source
World Health Organization – processed by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
46 places, 280 data points, 2016–2022
Last refreshed

Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).